This document is an excerpt from the EUR-Lex website
Document 62019TA0104
Case T-104/19: Judgment of the General Court of 25 June 2020 — Dermavita v EUIPO — Allergan Holdings France (JUVÉDERM) (EU trade mark — Revocation proceedings — EU word mark JUVÉDERM — Genuine use of the mark — Use in connection with the goods in respect of which the mark was registered — Use in the form in which the mark was registered — Use with the proprietor’s consent — Article 51(1)(a) of Regulation (EC) No 207/2009 (now Article 58(1)(a) of Regulation (EU) 2017/1001))
Case T-104/19: Judgment of the General Court of 25 June 2020 — Dermavita v EUIPO — Allergan Holdings France (JUVÉDERM) (EU trade mark — Revocation proceedings — EU word mark JUVÉDERM — Genuine use of the mark — Use in connection with the goods in respect of which the mark was registered — Use in the form in which the mark was registered — Use with the proprietor’s consent — Article 51(1)(a) of Regulation (EC) No 207/2009 (now Article 58(1)(a) of Regulation (EU) 2017/1001))
Case T-104/19: Judgment of the General Court of 25 June 2020 — Dermavita v EUIPO — Allergan Holdings France (JUVÉDERM) (EU trade mark — Revocation proceedings — EU word mark JUVÉDERM — Genuine use of the mark — Use in connection with the goods in respect of which the mark was registered — Use in the form in which the mark was registered — Use with the proprietor’s consent — Article 51(1)(a) of Regulation (EC) No 207/2009 (now Article 58(1)(a) of Regulation (EU) 2017/1001))
OJ C 262, 10.8.2020, p. 21–22
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
10.8.2020 |
EN |
Official Journal of the European Union |
C 262/21 |
Judgment of the General Court of 25 June 2020 — Dermavita v EUIPO — Allergan Holdings France (JUVÉDERM)
(Case T-104/19) (1)
(EU trade mark - Revocation proceedings - EU word mark JUVÉDERM - Genuine use of the mark - Use in connection with the goods in respect of which the mark was registered - Use in the form in which the mark was registered - Use with the proprietor’s consent - Article 51(1)(a) of Regulation (EC) No 207/2009 (now Article 58(1)(a) of Regulation (EU) 2017/1001))
(2020/C 262/28)
Language of the case: English
Parties
Applicant: Dermavita Co. Ltd (Beirut, Lebanon) (represented by: G. Paricheva, lawyer)
Defendant: European Union Intellectual Property Office (represented by: K. Zajfert, J. Crespo Carrillo, H. O’Neill and V. Ruzek, acting as Agents)
Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Allergan Holdings France (Courbevoie, France) (represented by: J. Day, Solicitor, and T. de Haan, lawyer)
Re:
Action brought against the decision of the Fourth Board of Appeal of EUIPO of 19 December 2018 (Case R 2630/2017-4), relating to revocation proceedings between Dermavita and Allergan Holdings France.
Operative part of the judgment
The Court:
|
1. |
Dismisses the action; |
|
2. |
Orders Dermavita Co. Ltd to bear its own costs and to pay those incurred by the European Union Intellectual Property Office (EUIPO); |
|
3. |
Orders Allergan Holdings France to bear its own costs. |